## AACR on Campus, Kuala Lumpur (Mohd Suffian Azizan: Cancer Research Malaysia – Poster LB-4)

### Key References

Below are the list of references that form the literature foundation of this project, cited in the poster titled ***'NeonDisco: Nextflow-based Recurrent Fusion Neoantigen Pipeline'***.

* Fatumo, S., Chikowore, T., Choudhury, A. et al. *A roadmap to increase diversity in genomic studies.* Nat Med 28, 243–250 (2022). [Fatumo et al., 2022](https://doi.org/10.1038/s41591-021-01672-4)
* Fotakis G, Rieder D, Haider M, Trajanoski Z, Finotello F. *NeoFuse: predicting fusion neoantigens from RNA sequencing data.* Bioinformatics. 2020 Apr 1;36(7):2260-2261. [NeoFuse: Fotakis et al., 2020](https://10.1093/bioinformatics/btz879)
* Huber, F., Arnaud, M., Stevenson, B.J. et al. *A comprehensive proteogenomic pipeline for neoantigen discovery to advance personalized cancer immunotherapy.* Nat Biotechnol 43, 1360–1372 (2025). [NeoDisc: Huber et al., 2020](https://doi.org/10.1038/s41587-024-02420-y)
* Tawfik, S.M., Elhosseiny, A.A., Galal, A.A. et al. *Health inequity in genomic personalized medicine in underrepresented populations: a look at the current evidence*. Funct Integr Genomics 23, 54 (2023). [Tawfik et al., 2023](https://doi.org/10.1007/s10142-023-00979-4)
* Weber D, Ibn-Salem J, Sorn P, Suchan M, Holtsträter C, Lahrmann U, Vogler I, Schmoldt K, Lang F, Schrörs B, Löwer M, Sahin U. *Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens.* Nat Biotechnol. 2022 Aug;40(8):1276-1284. [EasyFuse: Weber et al., 2022](https://10.1038/s41587-022-01247-9)


**NOTE:** Click here to go to the [homepage of NeonDisco](https://github.com/cancer-research-malaysia/NeonDisco)
